+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030- Product Image
Urinary Tract Infection Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030- Product Image
Sale

Urinary Tract Infection Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666357
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection testing market is rapidly evolving, driven by escalating clinical demands, advances in diagnostic technologies, and a shifting regulatory landscape. As stakeholders seek data-driven guidance for strategic decisions, understanding this dynamic sector is more critical than ever.

Market Snapshot: Urinary Tract Infection Testing Market

The global market for urinary tract infection testing grew from USD 1.47 billion in 2024 to USD 1.54 billion in 2025 and is projected to reach USD 1.94 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.78%. This growth is underpinned by the increasing clinical and economic impact of urinary tract infections worldwide, as well as continuous innovation in detection methods. Market participants include laboratory solution providers, device manufacturers, policymakers, and healthcare administrators, each seeking strategic clarity in a complex environment.

Scope & Segmentation: Comprehensive Overview

Spanning technologies, modalities, and global regions, this report provides actionable intelligence across all crucial segments of the urinary tract infection testing market:

  • Test Types: Automated urinalysis, culture tests, molecular assays (including next generation sequencing and isothermal amplification), and rapid tests such as dipstick platforms and microscopy-based kits
  • Technologies: Automated systems, culture-based methods, advanced immunoassays (chemiluminescent, ELISA, lateral flow), and molecular diagnostics
  • End Users: Clinics, diagnostic laboratories, home care settings, and hospitals
  • Distribution Channels: Direct tender models, e-commerce, hospital pharmacy, and retail pharmacy networks
  • Sample Types: Catheterized, midstream clean catch, and suprapubic aspiration
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, Turkey), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, and more)
  • Companies Profiled: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., bioMérieux SA, Sysmex Corporation, Ortho Clinical Diagnostics, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc.

Key Takeaways for Senior Decision-Makers

  • Diagnostic pathways now integrate automated analysis, culture, molecular, and rapid testing to meet evolving clinical requirements and address antimicrobial resistance concerns.
  • Adoption of decentralized and point-of-care solutions is increasing, driven by demand for faster turnaround times and expanded access, particularly in community and home-based settings.
  • Strategic mergers, acquisitions, and partnerships are consolidating the market, enhancing R&D capabilities, and broadening access to innovative platforms.
  • Regional differences in regulatory standards, reimbursement, and laboratory infrastructure significantly affect test adoption and highlight the need for tailored commercial strategies.
  • Investment in digital connectivity and cloud analytics is fostering integration between diagnostic devices and healthcare data systems, enabling predictive insights and supporting value-based care models.

Tariff Impact: Navigating Cost and Supply Chain Risks

New US tariffs on imported laboratory instruments and diagnostic reagents have increased costs for clinical laboratories, driving some to prioritize local sourcing or domestic manufacturing partnerships. This shift is catalyzing operational innovation and supply chain resilience. Laboratories are also refining decision algorithms to balance cost control with diagnostic quality, ensuring patient access and optimal resource utilization under tighter economic conditions.

Methodology & Data Sources

This report synthesizes primary interviews with healthcare executives and laboratory directors alongside secondary research from peer-reviewed publications, regulatory filings, and proprietary data. Triangulation with quantitative and qualitative insights ensures robust findings, while rigorous review and validation protocols underpin data integrity throughout all stages of analysis.

Why This Report Matters: Urinary Tract Infection Testing Market

  • Provides a clear, actionable roadmap for optimizing diagnostic portfolio investments and aligning technology adoption with emerging clinical and commercial trends.
  • Equips decision-makers with detailed segmentation, regional analysis, and key player strategies to strengthen competitive positioning and manage evolving risks.
  • Supports development of supply chain and regulatory strategies that anticipate market shifts and secure long-term business sustainability.

Conclusion

With ongoing advances across testing platforms, regulatory policies, and commercial models, the urinary tract infection testing market presents opportunities for sustained growth. Armed with granular segmentation and strategic insights, industry leaders can drive innovation, enhance market reach, and deliver improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary Tract Infection Testing Market, by Test Type
8.1. Introduction
8.2. Automated Urinalysis
8.2.1. Automated Microscopy
8.2.2. Digital Imaging
8.2.3. Flow Cytometry
8.3. Culture Test
8.4. Molecular Test
8.4.1. Isothermal Amplification
8.4.2. Next Generation Sequencing
8.4.3. Pcr Assay
8.5. Rapid Test
8.5.1. Dipstick Test
8.5.2. Microscopy
9. Urinary Tract Infection Testing Market, by Technology
9.1. Introduction
9.2. Automated Systems
9.2.1. Fully Automated
9.2.2. Semi Automated
9.3. Culture Based
9.4. Immunoassays
9.4.1. Chemiluminescent Immunoassay
9.4.2. Elisa
9.4.3. Lateral Flow Assay
9.5. Molecular Diagnostics
9.5.1. Isothermal
9.5.2. Next Generation Sequencing
9.5.3. Pcr
10. Urinary Tract Infection Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Home Care
10.5. Hospitals
11. Urinary Tract Infection Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. E Commerce
11.4. Hospital Pharmacy
11.5. Retail Pharmacy
12. Urinary Tract Infection Testing Market, by Sample Type
12.1. Introduction
12.2. Catheterized
12.3. Midstream Clean Catch
12.4. Suprapubic Aspiration
13. Americas Urinary Tract Infection Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Urinary Tract Infection Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Urinary Tract Infection Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Danaher Corporation
16.3.4. Siemens Healthineers AG
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. Sysmex Corporation
16.3.8. Ortho Clinical Diagnostics, Inc.
16.3.9. QIAGEN N.V.
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. URINARY TRACT INFECTION TESTING MARKET MULTI-CURRENCY
FIGURE 2. URINARY TRACT INFECTION TESTING MARKET MULTI-LANGUAGE
FIGURE 3. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 78. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 79. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 80. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 82. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 83. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 90. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 91. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 145. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 146. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 147. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 156. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 157. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 158. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 160. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 176. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 177. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 178. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 179. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 180. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 183. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 189. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 190. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 191. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 194. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 232. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 234. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 235. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 237. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 238. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 253. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 254. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 255. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 256. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 257. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 260. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 261. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 266. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 267. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 268. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 297. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 298. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2030 (USD MILLION)
TABLE 299. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 300. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Urinary Tract Infection Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Sysmex Corporation
  • Ortho Clinical Diagnostics, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.94 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Urinary Tract Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 270 Pages
  • Global
From
Urinary Tract Infection Testing Devices Market Report 2025 - Product Image

Urinary Tract Infection Testing Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Urinary Tract Infection Testing - Global Strategic Business Report - Product Image

Urinary Tract Infection Testing - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 114 Pages
  • Global
From

About the Urinary Tract Infection Testing Market

The Urinary Tract Infection (UTI) Testing market is a subset of the Urology and Nephrology industry. It is focused on the diagnosis and treatment of UTIs, which are caused by bacteria entering the urinary tract. UTI testing is used to identify the presence of bacteria in the urine, as well as to determine the type of bacteria present. Tests may include urine cultures, urine microscopy, and urine antigen tests. Treatment typically involves antibiotics, and in some cases, surgery. The UTI Testing market is driven by the increasing prevalence of UTIs, as well as the need for accurate diagnosis and treatment. The market is expected to grow in the coming years, as new technologies and treatments are developed. Some companies in the UTI Testing market include Siemens Healthineers, Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.